Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
- 31 March 2001
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (2) , 135-140
- https://doi.org/10.1053/ejso.2000.1062
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853The Lancet, 2000
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999
- A prognostic index for ductal carcinoma in situ of the breastCancer, 1996
- Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)Cancer, 1995
- Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatmentCancer, 1993
- Noninvasive ductal carcinoma of the breast: The relevance of histologic categorizationHuman Pathology, 1993
- Ductal Carcinoma In Situ of the Female BreastThe American Journal of Surgical Pathology, 1992
- Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance aloneCancer, 1992
- Quality assurance of the EORTC trial 22881/10882: “assessment of the role of the booster dose in breast conserving therapy”: the Dummy RunRadiotherapy and Oncology, 1991
- Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1991